Comparative transcriptomic analysis and mechanistic characterization revealed the use of formononetin for bladder cancer treatment-Reference-Cited by-同舟云学术

Comparative transcriptomic analysis and mechanistic characterization revealed the use of formononetin for bladder cancer treatment

Published:2023 Issue:12 Volume:14 Page:5787-5804
ISSN:2042-6496
Container-title:Food & Function
language:en
Short-container-title:Food Funct.

Author:

Zhou Huanhuan¹²,Wang Ping¹²,Qin Xian³^ORCID,Zhang Xing¹²,Lai Keng Po¹²^ORCID,Chen Jian¹²

Affiliation:

1. Guangxi Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical University, No.1 Zhiyuan Road, Lingui District, Guilin 541004, China

2. Key Laboratory of Environmental Pollution and Integrative Omics, Guilin Medical University, Education Department of Guangxi Zhuang Autonomous Region, Guilin, China

3. Department of Chemistry, City University of Hong Kong, Hong Kong SAR, China

Abstract

Formononetin inhibits the recurrence and metastasis of bladder cancer through the regulation of oncogenes.

Funder

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Medicine,Food Science

Link

http://pubs.rsc.org/en/content/articlepdf/2023/FO/D2FO03962A

Reference60 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. K. L.Ng , The Etiology of Bladder Cancer , in Urologic Cancers , ed. N. Barber and A. Ali . Exon Publications , Brisbane (AU) , 2022 , ch. 3

3. Intravesical combination therapies for non-muscle invasive bladder cancer: Recent advances and future directions

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and Antitumor Activity Study of Novel Formononetin Derivatives;Russian Journal of Bioorganic Chemistry;2024-04

2. Design and Synthesis of Novel Anti-proliferative Formononetin Derivatives;Letters in Drug Design & Discovery;2024-03-04